Biogen Pharmachem Industries share news, announcements and annual reports
BIOGEN PHARMACHEM INDUSTRIES LIMITED · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1996
Last close ₹0.25₹0.00 (0.00%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹0.25.
30 Oct: open ₹0.25, high ₹0.25, low ₹0.24
52-week range of traded prices to 30 Oct 2026
₹0.23Low, 23 Oct 2026₹0.72High, 4 Nov 2025
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹26 Cr3,446th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.27
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −0.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 23,53,079
Biogen Pharmachem Industries board meetings
131 filed, newest first. Page 3 of 3.
Jan 2020
23 Jan · Board meeting
Meeting on 3 Feb 2020: quarterly results
Oct 2019
15 Oct · Board meeting
Meeting on 26 Oct 2019: quarterly results
Jul 2019
26 Jul · Board meeting
Meeting on 5 Aug 2019: quarterly results
May 2019
14 May · Board meeting
Meeting on 23 May 2019: audited results
Jan 2019
25 Jan · Board meeting
Meeting on 7 Feb 2019: quarterly results
Jun 2017
Mar 2017
Aug 2016
Oct 2015
19 Oct · Board meeting
Board of Directors of the Company at its meeting held on October 19, 2015, inter alia, has taken on record the following transactions: ....
Sep 2015
3 Sep · Board meeting
Board of Directors of the Company at its meeting held on September 03, 2015, inter alia, has considered the following: - To accept ....
Aug 2015
28 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 28, 2015, inter alia, has considered the following: 1. To Appoint ....
Mar 2015
2 Mar · Board meeting
Board of Directors of the Company at its meeting held on March 02, 2015, inter alia, has considered the following: 1. To Appoint ....
Aug 2014
27 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 27, 2014, inter alia, has considered the following; 1. The Board ....
Jun 2014
23 Jun · Board meeting
Board of Directors of the Company at its meeting held on June 23, 2014, inter alia, has considered the following: - To accept resignation ....
May 2014
2 May · Board meeting
Board of Directors of the Company at its meeting held on May 01, 2014, inter alia, has considered the following: 1. Considered and ....
Feb 2014
20 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 20, 2014, inter alia, has considered the following: - To appoint ....
Jan 2014
6 Jan · Board meeting
Board of Directors of the Company at its meeting held on January 06, 2014, inter alia, has considered the following: 1. To accept ....
Dec 2013
31 Dec · Board meeting
Board of Directors of the Company at its meeting held on December 31, 2013, inter alia, has considered and approved the following: ....
Dec 2011
22 Dec · Board meeting
Board of Directors of the Company at its meeting held on December 22, 2011, has taken the following decisions: 1. Accept the resignation ....
Apr 2011
8 Apr · Board meeting
Board of Director at its meeting Held on April 08, 2011, inter alia, taken the following decisions : 1. To Change the name of the ....
Jul 2010
2 Jul · Board meeting
Board of Directors of the Company at its meeting held on July 02, 2010, has appointed Mr. Nilesh T. Kava as Additional Director of the ....
Jun 2010
Mar 2010